Halts

FDA Halts Approval for Plasma to Treat COVID-19

Aug. 20, 2020 — U.S. Food and Drug Administration’s emergency approval of blood plasma as a COVID-19 treatment was put on hold last week after senior federal health officials said data supporting the therapy was too weak. More data is…